oral glp-1 medications approved Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Oral GLP-1 Pill Delivers Injection-Like

I think NPs just look at the whole person

In a 40-week Phase 3 trial, adults with type 2 diabetes taking 12 mg of retatrutide shed an average of 16.8% (36.6 lbs) of their beginning weight

Qualifying for semaglutide typically requires a BMI of 30 or higher (or 27 with a comorbidity)

Elad S, Marshall J, Meyerowitz C, Connolly G

Hence, because injections transfer Glutathione directly into the circulation, therefore, it causes faster and more evident effects than oral supplements

In SURMOUNT-1, a study in 2,539 adults with obesity, or excess weight and weight-related medical problems not including diabetes, people taking Zepbound as an adjunct to diet and exercise experienced substantial weight loss compared with placebo at 72 weeks